INTRODUCTION: High-resolution array comparative genomic hybridization (aCGH) is a method of evaluating chromosomal alterations over the entire genome. We compared aCGH with routine cytogenetics and FISH in detecting genetic alterations in chronic lymphocytic leukemia (CLL). METHODS: Array comparative genomic hybridization testing was performed on 55 cases of CLL in addition to a standard panel of FISH probes (ATM on 11q22, trisomy 12, 13q14, p53 on 17p13). The frequency of detecting abnormalities was compared, and discordant results between methodologies were compared. RESULTS: Fifty-five CLL cases [male to female ratio of 2.2:1 and a mean age of 71 (52-90)] were analyzed by both aCGH and FISH. This group of CLL cases showed genetic abnormalities by FISH (60%; 27/45). In contrast to FISH, aCGH detected genetic abnormalities in 82% (45/55) of CLL cases; aCGH identified genetic abnormalities not detected by FISH studies in 16% (7/45) of cases, whereas FISH identified abnormalities not detected by aCGH in only 7% (3/45) of cases. Rare recurring genetic alterations were detected by aCGH including losses in 6q, 8p, 10q, 14q32, and 18q and gains in 10q. DISCUSSION: Our findings suggest aCGH is an effective technique for evaluating recurring genetic abnormalities in CLL and improves on standard FISH in detecting genetic abnormalities in CLL.
INTRODUCTION: High-resolution array comparative genomic hybridization (aCGH) is a method of evaluating chromosomal alterations over the entire genome. We compared aCGH with routine cytogenetics and FISH in detecting genetic alterations in chronic lymphocytic leukemia (CLL). METHODS: Array comparative genomic hybridization testing was performed on 55 cases of CLL in addition to a standard panel of FISH probes (ATM on 11q22, trisomy 12, 13q14, p53 on 17p13). The frequency of detecting abnormalities was compared, and discordant results between methodologies were compared. RESULTS: Fifty-five CLL cases [male to female ratio of 2.2:1 and a mean age of 71 (52-90)] were analyzed by both aCGH and FISH. This group of CLL cases showed genetic abnormalities by FISH (60%; 27/45). In contrast to FISH, aCGH detected genetic abnormalities in 82% (45/55) of CLL cases; aCGH identified genetic abnormalities not detected by FISH studies in 16% (7/45) of cases, whereas FISH identified abnormalities not detected by aCGH in only 7% (3/45) of cases. Rare recurring genetic alterations were detected by aCGH including losses in 6q, 8p, 10q, 14q32, and 18q and gains in 10q. DISCUSSION: Our findings suggest aCGH is an effective technique for evaluating recurring genetic abnormalities in CLL and improves on standard FISH in detecting genetic abnormalities in CLL.
Authors: Fady M Mikhail; Nyla A Heerema; Kathleen W Rao; Rachel D Burnside; Athena M Cherry; Linda D Cooley Journal: Genet Med Date: 2016-04-28 Impact factor: 8.822
Authors: Eyad Alhourani; Martina Rincic; Joana B Melo; Isabel M Carreira; Anita Glaser; Beate Pohle; Cordula Schlie; Thomas Liehr Journal: Leuk Res Treatment Date: 2015-11-30
Authors: Marian Jpl Stevens-Kroef; Eva van den Berg; Daniel Olde Weghuis; Ad Geurts van Kessel; Rolph Pfundt; Matty Linssen-Wiersma; Marloes Benjamins; Trijnie Dijkhuizen; Patricia Jta Groenen; Annet Simons Journal: Mol Cytogenet Date: 2014-01-09 Impact factor: 2.009
Authors: Jan Smetana; Jan Frohlich; Romana Zaoralova; Vladimira Vallova; Henrieta Greslikova; Renata Kupska; Pavel Nemec; Aneta Mikulasova; Martina Almasi; Ludek Pour; Zdenek Adam; Viera Sandecka; Lenka Zahradová; Roman Hajek; Petr Kuglik Journal: Biomed Res Int Date: 2014-06-02 Impact factor: 3.411
Authors: Alexander C Leeksma; Panagiotis Baliakas; Theodoros Moysiadis; Anna Puiggros; Karla Plevova; Anne-Marie Van der Kevie-Kersemaekers; Hidde Posthuma; Ana E Rodriguez-Vicente; Anh Nhi Tran; Gisela Barbany; Larry Mansouri; Rebeqa Gunnarsson; Helen Parker; Eva Van den Berg; Mar Bellido; Zadie Davis; Meaghan Wall; Ilaria Scarpelli; Anders Österborg; Lotta Hansson; Marie Jarosova; Paolo Ghia; Pino Poddighe; Blanca Espinet; Sarka Pospisilova; Constantine Tam; Loïc Ysebaert; Florence Nguyen-Khac; David Oscier; Claudia Haferlach; Jacqueline Schoumans; Marian Stevens-Kroef; Eric Eldering; Kostas Stamatopoulos; Richard Rosenquist; Jonathan C Strefford; Clemens Mellink; Arnon P Kater Journal: Haematologica Date: 2021-01-01 Impact factor: 9.941